Company Filing History:
Years Active: 2022
Title: Hyeon Jeong Choe: Innovator in Cancer Treatment
Introduction
Hyeon Jeong Choe is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative treatments for cancer. His work focuses on creating compounds that can effectively target specific mutations associated with cancer.
Latest Patents
Hyeon Jeong Choe holds a patent for a compound known as N2,N4-diphenylpyrimidine-2,4-diamine derivative. This invention includes a method for preparing the compound and a pharmaceutical composition that utilizes it as an active ingredient for the prevention or treatment of cancer. The derivative demonstrates a relatively weak inhibitory effect on wild-type EGFR but shows a high inhibitory ability on EGFR mutations, as well as FLT3 and its mutations. This makes it a promising candidate for treating cancers associated with these mutations.
Career Highlights
Choe is affiliated with the Korea Research Institute of Chemical Technology, where he conducts research and development in chemical technology. His work has been instrumental in advancing the understanding of cancer treatment options and developing new therapeutic strategies.
Collaborations
Hyeon Jeong Choe collaborates with esteemed colleagues, including Kwangho Lee and Inji Shin. Their combined expertise contributes to the innovative research being conducted at their institution.
Conclusion
Hyeon Jeong Choe's contributions to cancer treatment through his patented inventions highlight the importance of innovation in the pharmaceutical industry. His work not only advances scientific knowledge but also offers hope for effective cancer therapies.